Painkiller developer Collegium Pharmaceutical has agreed to pay $2.75 million to settle more than two dozen opioid-related lawsuits.
Collegium (Nasdaq: COLL) also agreed to pay the state of Massachusetts $185,000 and stop marketing its opioids in person earlier this month, resolving allegations of what Attorney General Maura Healey described as "unfair and deceptive practices."
More on this story from Boston Business Journal
Get Boston local news, weather forecasts, lifestyle and entertainment stories to your inbox. Sign up for NBC Boston’s newsletters.
Copyright Boston Business Journal